Atlas Trials

A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes

Clinical trial NCT07087795 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07087795
Sponsor
Novo Nordisk A/S
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2025-07-01
Primary completion
2026-09-12
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.